UHMBT has pledged to achieve the very best standards of care for patients with breast cancer in Morecambe Bay as part of an initiative in collaboration with the UK’s leading breast cancer charity, Breast Cancer Now.
Breast Cancer Now’s Service Pledge – jointly sponsored by Eli Lilly and Company Ltd and Roche Products Ltd (2022-2023) - is a programme dedicated to improving breast cancer services by bringing together patients, healthcare professionals and Cancer Alliances to work in partnership.
The Service Pledge is the only breast cancer specific patient involvement and service improvement programme in the UK. Since 2003, the innovative programme has been delivering lasting positive change in everyone’s experience of breast cancer and now has a crucial role to play in future-proofing breast cancer services in the wake of the impacts of the COVID-19 pandemic.
The Service Pledge will see UHMBT working collaboratively with Breast Cancer Now over the next few months. During this time, patients living with both primary and incurable secondary breast cancer will be given a platform through patient surveys and workshops to voice what matters most to them and use their experiences to help identify and shape improvements for the future.
UHMBT will then publicly pledge to implementing agreed changes, as a commitment to their patients.
Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said:
“We’re delighted that UHMBT has pledged to achieve the very best standards of care for people with breast cancer in Morecambe Bay.
“The Service Pledge supports patients to share their experiences and what matters most to them about their local service with their Hospital, enabling all parties to work together and develop and deliver concrete improvements that mean patients get the best care possible.
“I am confident that the patient-led service improvements that will be implemented as a result of UHMBT signing up to our Service Pledge will make a huge positive difference to patients at what is already a difficult time following a breast cancer diagnosis.”